nodes	percent_of_prediction	percent_of_DWPC	metapath
Cephalexin—SLC22A5—Dactinomycin—muscle cancer	0.409	0.493	CbGbCtD
Cephalexin—SLC22A8—Methotrexate—muscle cancer	0.125	0.15	CbGbCtD
Cephalexin—SLC22A6—Methotrexate—muscle cancer	0.0868	0.105	CbGbCtD
Cephalexin—ALB—Methotrexate—muscle cancer	0.0739	0.0892	CbGbCtD
Cephalexin—CYP3A4—Vincristine—muscle cancer	0.0383	0.0462	CbGbCtD
Cephalexin—CYP2D6—Doxorubicin—muscle cancer	0.0376	0.0454	CbGbCtD
Cephalexin—CYP3A4—Etoposide—muscle cancer	0.0351	0.0423	CbGbCtD
Cephalexin—CYP3A4—Doxorubicin—muscle cancer	0.0239	0.0289	CbGbCtD
Cephalexin—Anorectal discomfort—Etoposide—muscle cancer	0.00382	0.0223	CcSEcCtD
Cephalexin—Nephropathy toxic—Etoposide—muscle cancer	0.00364	0.0213	CcSEcCtD
Cephalexin—Aplastic anaemia—Dactinomycin—muscle cancer	0.00271	0.0158	CcSEcCtD
Cephalexin—Prothrombin level increased—Doxorubicin—muscle cancer	0.00264	0.0154	CcSEcCtD
Cephalexin—Lactic dehydrogenase activity increased—Doxorubicin—muscle cancer	0.00212	0.0124	CcSEcCtD
Cephalexin—Phosphatase alkaline increased—Etoposide—muscle cancer	0.00209	0.0122	CcSEcCtD
Cephalexin—Vaginal discharge—Methotrexate—muscle cancer	0.00206	0.012	CcSEcCtD
Cephalexin—Anorectal discomfort—Doxorubicin—muscle cancer	0.00198	0.0116	CcSEcCtD
Cephalexin—Toxic epidermal necrolysis—Dactinomycin—muscle cancer	0.00189	0.011	CcSEcCtD
Cephalexin—Aspartate aminotransferase increased—Dactinomycin—muscle cancer	0.00189	0.011	CcSEcCtD
Cephalexin—Blood lactate dehydrogenase increased—Doxorubicin—muscle cancer	0.00187	0.0109	CcSEcCtD
Cephalexin—Vaginal discharge—Doxorubicin—muscle cancer	0.00178	0.0104	CcSEcCtD
Cephalexin—Blood alkaline phosphatase increased—Etoposide—muscle cancer	0.00175	0.0102	CcSEcCtD
Cephalexin—Pancytopenia—Dactinomycin—muscle cancer	0.00172	0.01	CcSEcCtD
Cephalexin—Neutropenia—Dactinomycin—muscle cancer	0.00169	0.00989	CcSEcCtD
Cephalexin—Aspartate aminotransferase increased—Vincristine—muscle cancer	0.00169	0.00985	CcSEcCtD
Cephalexin—Stevens-Johnson syndrome—Dactinomycin—muscle cancer	0.0016	0.00935	CcSEcCtD
Cephalexin—Pancytopenia—Vincristine—muscle cancer	0.00154	0.00898	CcSEcCtD
Cephalexin—Neutropenia—Vincristine—muscle cancer	0.00151	0.00884	CcSEcCtD
Cephalexin—Agranulocytosis—Dactinomycin—muscle cancer	0.00151	0.0088	CcSEcCtD
Cephalexin—Hepatitis—Dactinomycin—muscle cancer	0.00145	0.00847	CcSEcCtD
Cephalexin—Erythema multiforme—Dactinomycin—muscle cancer	0.00137	0.00801	CcSEcCtD
Cephalexin—Toxic epidermal necrolysis—Etoposide—muscle cancer	0.00137	0.00798	CcSEcCtD
Cephalexin—Alanine aminotransferase increased—Etoposide—muscle cancer	0.00134	0.00781	CcSEcCtD
Cephalexin—Hallucination—Vincristine—muscle cancer	0.00129	0.00753	CcSEcCtD
Cephalexin—Urinary tract disorder—Vincristine—muscle cancer	0.00128	0.00747	CcSEcCtD
Cephalexin—Connective tissue disorder—Vincristine—muscle cancer	0.00127	0.00744	CcSEcCtD
Cephalexin—Urethral disorder—Vincristine—muscle cancer	0.00127	0.00742	CcSEcCtD
Cephalexin—Vaginal inflammation—Methotrexate—muscle cancer	0.00125	0.00731	CcSEcCtD
Cephalexin—Pancytopenia—Etoposide—muscle cancer	0.00125	0.00727	CcSEcCtD
Cephalexin—Jaundice cholestatic—Doxorubicin—muscle cancer	0.00123	0.0072	CcSEcCtD
Cephalexin—Neutropenia—Etoposide—muscle cancer	0.00123	0.00716	CcSEcCtD
Cephalexin—Arthropathy—Doxorubicin—muscle cancer	0.00119	0.00696	CcSEcCtD
Cephalexin—Vaginal infection—Methotrexate—muscle cancer	0.00118	0.0069	CcSEcCtD
Cephalexin—Aplastic anaemia—Methotrexate—muscle cancer	0.00118	0.00686	CcSEcCtD
Cephalexin—Infestation NOS—Etoposide—muscle cancer	0.00117	0.00683	CcSEcCtD
Cephalexin—Infestation—Etoposide—muscle cancer	0.00117	0.00683	CcSEcCtD
Cephalexin—Stevens-Johnson syndrome—Etoposide—muscle cancer	0.00116	0.00677	CcSEcCtD
Cephalexin—Blood bilirubin increased—Doxorubicin—muscle cancer	0.00115	0.00669	CcSEcCtD
Cephalexin—Creatinine increased—Doxorubicin—muscle cancer	0.00114	0.00665	CcSEcCtD
Cephalexin—Mental disorder—Vincristine—muscle cancer	0.00114	0.00663	CcSEcCtD
Cephalexin—Leukopenia—Dactinomycin—muscle cancer	0.00113	0.0066	CcSEcCtD
Cephalexin—Hepatobiliary disease—Etoposide—muscle cancer	0.00111	0.00646	CcSEcCtD
Cephalexin—Agranulocytosis—Etoposide—muscle cancer	0.00109	0.00637	CcSEcCtD
Cephalexin—Vaginal inflammation—Doxorubicin—muscle cancer	0.00108	0.00633	CcSEcCtD
Cephalexin—Phosphatase alkaline increased—Doxorubicin—muscle cancer	0.00108	0.00633	CcSEcCtD
Cephalexin—Colitis—Doxorubicin—muscle cancer	0.00104	0.00608	CcSEcCtD
Cephalexin—Urinary tract disorder—Etoposide—muscle cancer	0.00104	0.00605	CcSEcCtD
Cephalexin—Agitation—Vincristine—muscle cancer	0.00104	0.00605	CcSEcCtD
Cephalexin—Urethral disorder—Etoposide—muscle cancer	0.00103	0.00601	CcSEcCtD
Cephalexin—Blood urea increased—Doxorubicin—muscle cancer	0.00102	0.00598	CcSEcCtD
Cephalexin—Vaginal infection—Doxorubicin—muscle cancer	0.00102	0.00598	CcSEcCtD
Cephalexin—Aplastic anaemia—Doxorubicin—muscle cancer	0.00102	0.00594	CcSEcCtD
Cephalexin—Leukopenia—Vincristine—muscle cancer	0.00101	0.0059	CcSEcCtD
Cephalexin—Thrombocytopenia—Dactinomycin—muscle cancer	0.00101	0.00589	CcSEcCtD
Cephalexin—Erythema multiforme—Etoposide—muscle cancer	0.000993	0.0058	CcSEcCtD
Cephalexin—Convulsion—Vincristine—muscle cancer	0.000978	0.00571	CcSEcCtD
Cephalexin—Immune system disorder—Etoposide—muscle cancer	0.000948	0.00554	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000939	0.00548	CcSEcCtD
Cephalexin—Anaphylactic shock—Vincristine—muscle cancer	0.000921	0.00538	CcSEcCtD
Cephalexin—Osteoarthritis—Methotrexate—muscle cancer	0.000909	0.00531	CcSEcCtD
Cephalexin—Blood alkaline phosphatase increased—Doxorubicin—muscle cancer	0.000905	0.00528	CcSEcCtD
Cephalexin—Nervous system disorder—Vincristine—muscle cancer	0.000903	0.00527	CcSEcCtD
Cephalexin—Thrombocytopenia—Vincristine—muscle cancer	0.000902	0.00526	CcSEcCtD
Cephalexin—Hepatic function abnormal—Doxorubicin—muscle cancer	0.000901	0.00526	CcSEcCtD
Cephalexin—Fatigue—Dactinomycin—muscle cancer	0.000889	0.00519	CcSEcCtD
Cephalexin—Feeling abnormal—Dactinomycin—muscle cancer	0.000849	0.00496	CcSEcCtD
Cephalexin—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000843	0.00492	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000839	0.0049	CcSEcCtD
Cephalexin—Breast disorder—Methotrexate—muscle cancer	0.000822	0.0048	CcSEcCtD
Cephalexin—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.000819	0.00478	CcSEcCtD
Cephalexin—Leukopenia—Etoposide—muscle cancer	0.000818	0.00478	CcSEcCtD
Cephalexin—Abdominal pain—Dactinomycin—muscle cancer	0.000815	0.00476	CcSEcCtD
Cephalexin—Body temperature increased—Dactinomycin—muscle cancer	0.000815	0.00476	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Vincristine—muscle cancer	0.000795	0.00464	CcSEcCtD
Cephalexin—Fatigue—Vincristine—muscle cancer	0.000794	0.00463	CcSEcCtD
Cephalexin—Convulsion—Etoposide—muscle cancer	0.000792	0.00462	CcSEcCtD
Cephalexin—Osteoarthritis—Doxorubicin—muscle cancer	0.000787	0.0046	CcSEcCtD
Cephalexin—Eosinophilia—Methotrexate—muscle cancer	0.000778	0.00454	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000773	0.00451	CcSEcCtD
Cephalexin—Hypersensitivity—Dactinomycin—muscle cancer	0.000759	0.00443	CcSEcCtD
Cephalexin—Gastrointestinal pain—Vincristine—muscle cancer	0.000753	0.0044	CcSEcCtD
Cephalexin—Confusional state—Etoposide—muscle cancer	0.000752	0.00439	CcSEcCtD
Cephalexin—Pancytopenia—Methotrexate—muscle cancer	0.000746	0.00436	CcSEcCtD
Cephalexin—Anaphylactic shock—Etoposide—muscle cancer	0.000746	0.00435	CcSEcCtD
Cephalexin—Asthenia—Dactinomycin—muscle cancer	0.00074	0.00432	CcSEcCtD
Cephalexin—Blood creatinine increased—Doxorubicin—muscle cancer	0.000738	0.0043	CcSEcCtD
Cephalexin—Neutropenia—Methotrexate—muscle cancer	0.000735	0.00429	CcSEcCtD
Cephalexin—Thrombocytopenia—Etoposide—muscle cancer	0.00073	0.00426	CcSEcCtD
Cephalexin—Abdominal pain—Vincristine—muscle cancer	0.000728	0.00425	CcSEcCtD
Cephalexin—Body temperature increased—Vincristine—muscle cancer	0.000728	0.00425	CcSEcCtD
Cephalexin—Skin disorder—Etoposide—muscle cancer	0.000725	0.00423	CcSEcCtD
Cephalexin—Breast disorder—Doxorubicin—muscle cancer	0.000711	0.00415	CcSEcCtD
Cephalexin—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.000709	0.00414	CcSEcCtD
Cephalexin—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.000709	0.00414	CcSEcCtD
Cephalexin—Diarrhoea—Dactinomycin—muscle cancer	0.000705	0.00412	CcSEcCtD
Cephalexin—Infestation—Methotrexate—muscle cancer	0.000701	0.00409	CcSEcCtD
Cephalexin—Infestation NOS—Methotrexate—muscle cancer	0.000701	0.00409	CcSEcCtD
Cephalexin—Gastritis—Doxorubicin—muscle cancer	0.000697	0.00407	CcSEcCtD
Cephalexin—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000695	0.00405	CcSEcCtD
Cephalexin—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.000694	0.00405	CcSEcCtD
Cephalexin—Hypersensitivity—Vincristine—muscle cancer	0.000678	0.00396	CcSEcCtD
Cephalexin—Eosinophilia—Doxorubicin—muscle cancer	0.000674	0.00393	CcSEcCtD
Cephalexin—Hepatobiliary disease—Methotrexate—muscle cancer	0.000663	0.00387	CcSEcCtD
Cephalexin—Asthenia—Vincristine—muscle cancer	0.000661	0.00386	CcSEcCtD
Cephalexin—Vomiting—Dactinomycin—muscle cancer	0.000655	0.00383	CcSEcCtD
Cephalexin—Agranulocytosis—Methotrexate—muscle cancer	0.000654	0.00382	CcSEcCtD
Cephalexin—Rash—Dactinomycin—muscle cancer	0.00065	0.00379	CcSEcCtD
Cephalexin—Pancytopenia—Doxorubicin—muscle cancer	0.000646	0.00377	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Etoposide—muscle cancer	0.000644	0.00376	CcSEcCtD
Cephalexin—Fatigue—Etoposide—muscle cancer	0.000643	0.00375	CcSEcCtD
Cephalexin—Neutropenia—Doxorubicin—muscle cancer	0.000636	0.00371	CcSEcCtD
Cephalexin—Haemoglobin—Methotrexate—muscle cancer	0.000632	0.00369	CcSEcCtD
Cephalexin—Diarrhoea—Vincristine—muscle cancer	0.00063	0.00368	CcSEcCtD
Cephalexin—Hepatitis—Methotrexate—muscle cancer	0.000629	0.00367	CcSEcCtD
Cephalexin—Haemorrhage—Methotrexate—muscle cancer	0.000629	0.00367	CcSEcCtD
Cephalexin—Urinary tract disorder—Methotrexate—muscle cancer	0.000621	0.00363	CcSEcCtD
Cephalexin—Urethral disorder—Methotrexate—muscle cancer	0.000617	0.0036	CcSEcCtD
Cephalexin—Feeling abnormal—Etoposide—muscle cancer	0.000615	0.00359	CcSEcCtD
Cephalexin—Nausea—Dactinomycin—muscle cancer	0.000612	0.00357	CcSEcCtD
Cephalexin—Gastrointestinal pain—Etoposide—muscle cancer	0.00061	0.00356	CcSEcCtD
Cephalexin—Dizziness—Vincristine—muscle cancer	0.000609	0.00355	CcSEcCtD
Cephalexin—Infestation—Doxorubicin—muscle cancer	0.000607	0.00354	CcSEcCtD
Cephalexin—Infestation NOS—Doxorubicin—muscle cancer	0.000607	0.00354	CcSEcCtD
Cephalexin—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000601	0.00351	CcSEcCtD
Cephalexin—Erythema multiforme—Methotrexate—muscle cancer	0.000595	0.00347	CcSEcCtD
Cephalexin—Urticaria—Etoposide—muscle cancer	0.000593	0.00346	CcSEcCtD
Cephalexin—Body temperature increased—Etoposide—muscle cancer	0.00059	0.00344	CcSEcCtD
Cephalexin—Abdominal pain—Etoposide—muscle cancer	0.00059	0.00344	CcSEcCtD
Cephalexin—Vomiting—Vincristine—muscle cancer	0.000586	0.00342	CcSEcCtD
Cephalexin—Rash—Vincristine—muscle cancer	0.000581	0.00339	CcSEcCtD
Cephalexin—Dermatitis—Vincristine—muscle cancer	0.00058	0.00339	CcSEcCtD
Cephalexin—Headache—Vincristine—muscle cancer	0.000577	0.00337	CcSEcCtD
Cephalexin—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000574	0.00335	CcSEcCtD
Cephalexin—Immune system disorder—Methotrexate—muscle cancer	0.000568	0.00332	CcSEcCtD
Cephalexin—Agranulocytosis—Doxorubicin—muscle cancer	0.000566	0.0033	CcSEcCtD
Cephalexin—Mental disorder—Methotrexate—muscle cancer	0.000551	0.00322	CcSEcCtD
Cephalexin—Hypersensitivity—Etoposide—muscle cancer	0.00055	0.00321	CcSEcCtD
Cephalexin—Haemoglobin—Doxorubicin—muscle cancer	0.000547	0.0032	CcSEcCtD
Cephalexin—Nausea—Vincristine—muscle cancer	0.000547	0.00319	CcSEcCtD
Cephalexin—Hepatitis—Doxorubicin—muscle cancer	0.000545	0.00318	CcSEcCtD
Cephalexin—Haemorrhage—Doxorubicin—muscle cancer	0.000545	0.00318	CcSEcCtD
Cephalexin—Urinary tract disorder—Doxorubicin—muscle cancer	0.000538	0.00314	CcSEcCtD
Cephalexin—Asthenia—Etoposide—muscle cancer	0.000535	0.00312	CcSEcCtD
Cephalexin—Connective tissue disorder—Doxorubicin—muscle cancer	0.000535	0.00312	CcSEcCtD
Cephalexin—Urethral disorder—Doxorubicin—muscle cancer	0.000534	0.00312	CcSEcCtD
Cephalexin—Pruritus—Etoposide—muscle cancer	0.000528	0.00308	CcSEcCtD
Cephalexin—Erythema multiforme—Doxorubicin—muscle cancer	0.000515	0.00301	CcSEcCtD
Cephalexin—Diarrhoea—Etoposide—muscle cancer	0.00051	0.00298	CcSEcCtD
Cephalexin—Dizziness—Etoposide—muscle cancer	0.000493	0.00288	CcSEcCtD
Cephalexin—Immune system disorder—Doxorubicin—muscle cancer	0.000492	0.00287	CcSEcCtD
Cephalexin—Leukopenia—Methotrexate—muscle cancer	0.00049	0.00286	CcSEcCtD
Cephalexin—Mental disorder—Doxorubicin—muscle cancer	0.000477	0.00279	CcSEcCtD
Cephalexin—Convulsion—Methotrexate—muscle cancer	0.000474	0.00277	CcSEcCtD
Cephalexin—Vomiting—Etoposide—muscle cancer	0.000474	0.00277	CcSEcCtD
Cephalexin—Rash—Etoposide—muscle cancer	0.00047	0.00275	CcSEcCtD
Cephalexin—Dermatitis—Etoposide—muscle cancer	0.00047	0.00274	CcSEcCtD
Cephalexin—Headache—Etoposide—muscle cancer	0.000467	0.00273	CcSEcCtD
Cephalexin—Arthralgia—Methotrexate—muscle cancer	0.000466	0.00272	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000463	0.0027	CcSEcCtD
Cephalexin—Confusional state—Methotrexate—muscle cancer	0.000451	0.00263	CcSEcCtD
Cephalexin—Anaphylactic shock—Methotrexate—muscle cancer	0.000447	0.00261	CcSEcCtD
Cephalexin—Nausea—Etoposide—muscle cancer	0.000443	0.00259	CcSEcCtD
Cephalexin—Nervous system disorder—Methotrexate—muscle cancer	0.000438	0.00256	CcSEcCtD
Cephalexin—Thrombocytopenia—Methotrexate—muscle cancer	0.000438	0.00255	CcSEcCtD
Cephalexin—Agitation—Doxorubicin—muscle cancer	0.000436	0.00254	CcSEcCtD
Cephalexin—Skin disorder—Methotrexate—muscle cancer	0.000434	0.00253	CcSEcCtD
Cephalexin—Leukopenia—Doxorubicin—muscle cancer	0.000424	0.00248	CcSEcCtD
Cephalexin—Convulsion—Doxorubicin—muscle cancer	0.000411	0.0024	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000407	0.00238	CcSEcCtD
Cephalexin—Arthralgia—Doxorubicin—muscle cancer	0.000404	0.00236	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000401	0.00234	CcSEcCtD
Cephalexin—Dyspepsia—Methotrexate—muscle cancer	0.000393	0.0023	CcSEcCtD
Cephalexin—Confusional state—Doxorubicin—muscle cancer	0.00039	0.00228	CcSEcCtD
Cephalexin—Anaphylactic shock—Doxorubicin—muscle cancer	0.000387	0.00226	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000386	0.00225	CcSEcCtD
Cephalexin—Fatigue—Methotrexate—muscle cancer	0.000385	0.00225	CcSEcCtD
Cephalexin—Nervous system disorder—Doxorubicin—muscle cancer	0.000379	0.00221	CcSEcCtD
Cephalexin—Thrombocytopenia—Doxorubicin—muscle cancer	0.000379	0.00221	CcSEcCtD
Cephalexin—Skin disorder—Doxorubicin—muscle cancer	0.000376	0.00219	CcSEcCtD
Cephalexin—Feeling abnormal—Methotrexate—muscle cancer	0.000368	0.00215	CcSEcCtD
Cephalexin—Gastrointestinal pain—Methotrexate—muscle cancer	0.000365	0.00213	CcSEcCtD
Cephalexin—Urticaria—Methotrexate—muscle cancer	0.000355	0.00207	CcSEcCtD
Cephalexin—Body temperature increased—Methotrexate—muscle cancer	0.000353	0.00206	CcSEcCtD
Cephalexin—Abdominal pain—Methotrexate—muscle cancer	0.000353	0.00206	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000353	0.00206	CcSEcCtD
Cephalexin—Dyspepsia—Doxorubicin—muscle cancer	0.000341	0.00199	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000334	0.00195	CcSEcCtD
Cephalexin—Fatigue—Doxorubicin—muscle cancer	0.000334	0.00195	CcSEcCtD
Cephalexin—Hypersensitivity—Methotrexate—muscle cancer	0.000329	0.00192	CcSEcCtD
Cephalexin—Asthenia—Methotrexate—muscle cancer	0.000321	0.00187	CcSEcCtD
Cephalexin—Feeling abnormal—Doxorubicin—muscle cancer	0.000319	0.00186	CcSEcCtD
Cephalexin—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000316	0.00185	CcSEcCtD
Cephalexin—Pruritus—Methotrexate—muscle cancer	0.000316	0.00185	CcSEcCtD
Cephalexin—Urticaria—Doxorubicin—muscle cancer	0.000307	0.00179	CcSEcCtD
Cephalexin—Body temperature increased—Doxorubicin—muscle cancer	0.000306	0.00179	CcSEcCtD
Cephalexin—Abdominal pain—Doxorubicin—muscle cancer	0.000306	0.00179	CcSEcCtD
Cephalexin—Diarrhoea—Methotrexate—muscle cancer	0.000306	0.00178	CcSEcCtD
Cephalexin—Dizziness—Methotrexate—muscle cancer	0.000295	0.00172	CcSEcCtD
Cephalexin—Hypersensitivity—Doxorubicin—muscle cancer	0.000285	0.00166	CcSEcCtD
Cephalexin—Vomiting—Methotrexate—muscle cancer	0.000284	0.00166	CcSEcCtD
Cephalexin—Rash—Methotrexate—muscle cancer	0.000282	0.00164	CcSEcCtD
Cephalexin—Dermatitis—Methotrexate—muscle cancer	0.000281	0.00164	CcSEcCtD
Cephalexin—Headache—Methotrexate—muscle cancer	0.00028	0.00163	CcSEcCtD
Cephalexin—Asthenia—Doxorubicin—muscle cancer	0.000278	0.00162	CcSEcCtD
Cephalexin—Pruritus—Doxorubicin—muscle cancer	0.000274	0.0016	CcSEcCtD
Cephalexin—Nausea—Methotrexate—muscle cancer	0.000265	0.00155	CcSEcCtD
Cephalexin—Diarrhoea—Doxorubicin—muscle cancer	0.000265	0.00155	CcSEcCtD
Cephalexin—Dizziness—Doxorubicin—muscle cancer	0.000256	0.00149	CcSEcCtD
Cephalexin—Vomiting—Doxorubicin—muscle cancer	0.000246	0.00144	CcSEcCtD
Cephalexin—Rash—Doxorubicin—muscle cancer	0.000244	0.00142	CcSEcCtD
Cephalexin—Dermatitis—Doxorubicin—muscle cancer	0.000244	0.00142	CcSEcCtD
Cephalexin—Headache—Doxorubicin—muscle cancer	0.000242	0.00141	CcSEcCtD
Cephalexin—Nausea—Doxorubicin—muscle cancer	0.00023	0.00134	CcSEcCtD
